268 related articles for article (PubMed ID: 30939936)
1. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report.
Gonzales M; Pipalia A; Weil A
J Investig Med High Impact Case Rep; 2019; 7():2324709619832324. PubMed ID: 30939936
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune heparin-induced thrombocytopenia.
Greinacher A; Selleng K; Warkentin TE
J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
[TBL] [Abstract][Full Text] [Related]
3. HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia.
Bauman MMJ; Naylor RM; Wijdicks EF
J Thromb Thrombolysis; 2021 Oct; 52(3):952-961. PubMed ID: 34089462
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia (HIT).
Evans NS; Gomes M
Vasc Med; 2017 Aug; 22(4):353-355. PubMed ID: 28606001
[No Abstract] [Full Text] [Related]
5. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
Nowak G
Thromb Haemost; 2009 Nov; 102(5):887-91. PubMed ID: 19888524
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST).
Buckley NA; Baskaya MK; Darsie ME
Neurocrit Care; 2021 Jun; 34(3):1103-1107. PubMed ID: 33000379
[No Abstract] [Full Text] [Related]
8. Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin.
Arcinas LA; Manji RA; Hrymak C; Dao V; Sheppard JI; Warkentin TE
Transfusion; 2019 Jun; 59(6):1924-1933. PubMed ID: 30903805
[TBL] [Abstract][Full Text] [Related]
9. Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology.
Choi PY; Uzun G; Bakchoul T;
J Thromb Haemost; 2024 Jun; 22(6):1772-1778. PubMed ID: 38301999
[TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.
Warkentin TE
Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032
[No Abstract] [Full Text] [Related]
11. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura.
Al-Riyami AZ; Lee J; Connolly M; Shereck E
Pediatr Blood Cancer; 2011 Jul; 57(1):157-9. PubMed ID: 21445949
[TBL] [Abstract][Full Text] [Related]
12. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
13. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis.
Ahmad S; Untch B; Haas S; Hoppensteadt DA; Misselwitz F; Messmore HL; Walenga JM; Fareed J
Mol Cell Biochem; 2004 Mar; 258(1-2):163-70. PubMed ID: 15030181
[TBL] [Abstract][Full Text] [Related]
14. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
Shih AW; Sheppard JI; Warkentin TE
Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
Dougherty JA; Yarsley RL
Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
[TBL] [Abstract][Full Text] [Related]
16. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.
Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH
Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S
Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713
[TBL] [Abstract][Full Text] [Related]
18. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
Manji F; Warkentin TE; Sheppard JI; Lee A
Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia.
Gleichgerrcht E; Lim MY; Turan TN
Neurologist; 2017 Nov; 22(6):241-244. PubMed ID: 29095327
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay.
Ramachandran P; Farag F; Morcus R; Gotlieb V
Am J Case Rep; 2019 Mar; 20():310-313. PubMed ID: 30850576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
